Abstract

CLC Number:

R743.3

高鹤, 江思瑜, 郭晓玲, 周博, 王新. 糖代谢紊乱与脑卒中的关系研究进展[J]. 承德医学院学报, 2022, 39(6): 505-510.

[1] Fuentes B, Ortega-Casarrubios MA, Sanjosé B, et al.Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome[J]. Stroke, 2010, 41(10): 2362-2365.
[2] Lee AK, Warren B, Lee CJ,et al.The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes[J]. Diabetes Care, 2018, 41(1): 104-111.
[3] Liao HW, Saver J, Yeh HC,et al.Low fasting glucose and future risks of major adverse outcomes in people without baseline diabetes or cardiovascular disease: a systematic review and meta-analysis[J]. BMJ Open, 2019, 9(7): e026010.
[4] Zhu B, Pan Y, Jing J, et al.Stress Hyperglycemia and Outcome of Non-diabetic Patients After Acute Ischemic Stroke[J]. Front Neurol, 2019, 10: 1003.
[5] Chen X, Liu Z, Miao J, et al.High Stress Hyperglycemia Ratio Predicts Poor Outcome after Mechanical Thrombectomy for Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2019, 28(6): 1668-1673.
[6] Xing L, Liu S, Tian Y, et al.C-R Relationship between Fasting Plasma Glucose and Unfavorable Outcomes in Patients of Ischemic Stroke withoutDiabetes[J]. J Stroke Cerebrovasc Dis, 2019, 28(5): 1400-1408.
[7] Zhang F, Zhang S, Tao C, et al.Association between serum glucose level and spot sign in intracerebral hemorrhage[J]. Medicine (Baltimore), 2019, 98(11): e14748.
[8] Gofir A, Mulyono B, Sutarni S.Hyperglycemia as a prognosis predictor of length of stay and functional outcomes in patients with acute ischemic stroke[J]. Int J Neurosci, 2017, 127(10): 923-929.
[9] Skafida A, Mitrakou A, Georgiopoulos G,et al.In-hospital dynamics of glucose, blood pressure and temperature predict outcome in patients with acute ischaemic stroke[J]. Eur Stroke J, 2018, 3(2): 174-184.
[10] Osei E, Fonville S, Zandbergen AAM, et al.Impaired fasting glucose is associated with unfavorable outcome in ischemic stroke patients treated with intravenous alteplase[J]. J Neurol, 2018, 265(6): 1426-1431.
[11] Cai Y, Wang C, Di W, et al.Correlation between blood glucose variability and the risk of death in patients with severe acute stroke[J]. Rev Neurol(Paris), 2020, 176(7-8): 582-586.
[12] Hui J, Zhang J, Mao X, et al.The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke[J]. Neurol Sci, 2018, 39(9): 1571-1577.
[13] Pan Y, Jing J, Wang Y, et al.Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients[J]. Neurol Res, 2018, 40(7): 573-580.
[14] Yang Chih-Jen, Liao Wen-I, Wang Jen-Chun, et al.Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke[J]. Am J Emerg Med, 2017, 35(9): 1240-1246.
[15] Roquer J, Giralt-Steinhauer E, Cerdà G, et al.Glycated Hemoglobin Value Combined with Initial Glucose Levels for Evaluating Mortality Risk in Patients with Ischemic Stroke[J]. Cerebrovasc Dis, 2015, 40(5-6): 244-250.
[16] Mitsios JP, Ekinci EI, Mitsios GP, et al.Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis[J]. J Am Heart Assoc, 2018, 7(11): e007758.
[17] Wang H, Cheng Y, Chen S, et al.Impact of Elevated Hemoglobin A1c Levels on Functional Outcome in Patients with Acute Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2019, 28(2): 470-476.
[18] Lattanzi S, Bartolini M, Provinciali L, et al.Glycosylated Hemoglobin and Functional Outcome after Acute Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2016, 25(7): 1786-1791.
[19] Zhang G, He M, Xu Y, et al.Hemoglobin A1c predicts hemorrhagic transformation and poor outcomes after acute anterior stroke[J]. Eur J Neurol, 2018, 25(12): 1432-e122.
[20] Abe A, Sakamoto Y, Nishiyama Y, et al.Decline in Hemoglobin during Hospitalization May Be Associated with Poor Outcome in Acute Stroke Patients[J]. J Stroke Cerebrovasc Dis, 2018, 27(6): 1646-1652.
[21] Pan Y, Jing J, Wang Y, et al.Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients[J]. Neurol Res, 2018,40(7): 573-580.
[22] Mukai N, Ninomiya T, Hata J, et al.Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study[J]. Cardiovasc Diabetol, 2015,14: 84.
[23] Ma Xi, Shen Y, Hu X, et al.Associations of glycated haemoglobin A1c and glycated albumin with subclinical atherosclerosis in middle-aged and elderly Chinese population with impaired glucose regulation[J]. Clin Exp Pharmacol Physiol, 2015, 42(6): 582-587.
[24] 冯小萌,纪蒙,王广. 糖化白蛋白对老年糖尿病患者再发脑梗死的影响[J]. 中国医师进修杂志,2016,39(5):440-443.
[25] Li J, Wang Y, Wang D, et al.Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke[J]. Neurology, 2015, 84(13): 1330-1336.
[26] Saliba W, Barnett-Griness O, Gronich N, et al.Association of Diabetes and Glycated Hemoglobin With the Risk of Intracerebral Hemorrhage: A Population-Based Cohort Study[J]. Diabetes Care, 2019, 42(4): 682-688.
[27] Hui J, Zhang J, Mao X, et al.The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke[J]. Neurol Sci, 2018, 39(9): 1571-1577.
[28] Jin C, Li G, Rexrode KM,et al.Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk[J]. Stroke, 2018, 49(1): 27-33.
[29] Fahim VF, Wadie W, Shafik AN, et al.Role of simvastatin and insulin in memory protection in a rat model of diabetes mellitus and dementia[J]. Brain Res Bull, 2019, 144: 21-27.
[30] Marissal-Arvy N, Campas Marie-Neige, Semont A, et al.Insulin treatment partially prevents cognitive and hippocampal alterations as well as glucocorticoid dysregulation in early-onset insulin-deficient diabetic rats[J]. Psychoneuroendocrinology, 2018, 93: 72-81.
[31] Serhan A, Aerts JL, Boddeke EWGM, et al.Neuroprotection by Insulin-like Growth Factor-1 in Rats with Ischemic Stroke is Associated with Microglial Changes and a Reduction in Neuroinflammation[J]. Neuroscience, 2020, 426: 101-114.
[32] Staszewski J, Brodacki B, Kotowicz J, et al.Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia[J]. J Stroke Cerebrovasc Dis, 2011, 20(2): 150-154.
[33] Zhu C, Chen J, Pan J, et al.Therapeutic effect of intensive glycemic control therapy in patients with traumatic brain injury: A systematic review and meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2018, 97(30): e11671.
[34] Rosso C, Corvol JC, Pires C, et al.Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial[J]. Stroke, 2012, 43(9): 2343-2349.
[35] McCormick M, Hadley D, McLean JR,et al. Randomized, controlled trial of insulin for acute poststroke hyperglycemia[J]. Ann Neurol, 2010, 67(5): 570-578.
[36] Lee YY, Lin YM, Leu WJ,et al.Sliding-scale insulin used for blood glucose control: a meta-analysis of randomized controlled trials[J]. Metabolism, 2015, 64(9): 1183-1192.
[37] Larsson M, Patrone C, von Euler M, et al. GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals[J]. Cardiovasc Diabetol, 2019, 18(1): 91.
[38] Basalay MV, Davidson SM, Yellon DM, et al.Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide[J]. Cardiovasc Drugs Ther, 2019, 33(6): 661-667.
[39] Filchenko I, Simanenkova A, Chefu S, et al.Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats[J]. Diab Vasc Dis Res, 2018, 15(6): 567-570.
[40] Kuroki T, Tanaka R, Shimada Y,et al.Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice[J]. Stroke, 2016, 47(5): 1328-1335.
[41] Zhang G, Kim S, Gu X, et al.DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic Effects[J]. Neurosci Bull, 2020, 36(4): 407-418.
[42] Chen L, Cao J, Cao D,et al.Protective effect of dexmedetomidine against diabetic hyperglycemia- exacerbated cerebralischemia/reperfusion injury: An in vivo and in vitro study[J]. Life Sci, 2019, 235: 116553.
[43] Huang HK, Yeh JI.Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis[J]. Diabetes Res Clin Pract, 2019, 152: 103-110.
[44] Huang K, Hu Y, Wu Y, et al.Exploratory analysis of oral glibenclamide in acute ischemic stroke[J]. Acta Neurol Scand, 2019, 140(3): 212-218.
[45] Inzucchi SE, Viscoli CM, Young LH,et al.Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease[J]. Diabetes Care, 2016, 9(10): 1684-1692.

糖代谢紊乱与脑卒中的关系研究进展

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	HU Su-juan, SUN Hui, XU Li-fang, LI Ling-ling, ZHOU Bo, GUO Xiao-ling. Comparison of Safety and Efficacy of Argatroban and Plasmin in the Treatment of Acute Ischemic Stroke [J]. Journal of Chengde Medical University, 2023, 40(2): 104-108.
[2]	. [J]. Journal of Chengde Medical University, 2023, 40(1): 69-71.
[3]	ZHOU Yuan, YE Bin, SUN Jing, GONG Xin. Relationship between PAI-1 Gene Polymorphism and Hemorrhagic Transformation and Vascular Reocclusion after Intravenous Thrombolysis with rt-PA in Ischemic Stroke [J]. Journal of Chengde Medical University, 2022, 39(2): 106-110.
[4]	HU Xue-song, XIE Bao-rong, CHEN Jian-mei. Effect of Three-tongue Acupuncture Combined with Ice Stimulation of Pharynx on Rehabilitation of Patients with Dysphagia after Stroke [J]. Journal of Chengde Medical University, 2021, 38(6): 485-490.
[5]	ZHANG Xiao-meng, ZHU Ya-qin, ZHANG Yan-hong, ZHOU Yan. Meta Analysis of Prognostic Factors in Stroke Patients with Dysphagia [J]. Journal of Chengde Medical University, 2021, 38(4): 281-287.
[6]	LI Xue-feng, WANG Qing-fang, FENG Yu-feng. Correlation of Lp-PLA2 and Annexin A2 with Prognosis in Patients with Acute Ischemic Stroke after Thrombolysis [J]. Journal of Chengde Medical University, 2021, 38(4): 301-305.
[7]	. [J]. Journal of Chengde Medical University, 2021, 38(3): 239-242.
[8]	LIU Meng-jie. Clinical Significance of Gene Detection in Patients with Ischemic Stroke [J]. Journal of Chengde Medical University, 2021, 38(1): 5-8.
[9]	. [J]. Journal of Chengde Medical University, 2019, 36(5): 399-405.
[10]	CHEN Xiao, ZHANG Yun-peng, DOU Zhi-jie, et al. RELATIONSHIPS BETWEEN APOLIPOPROTEIN B/A1, GLYCOSYLATED HEMOGLOBIN LEVEL AND VENOUS THROMBOLYSIS OUTCOME IN CEREBRAL INFARCTION PATIENTS [J]. Journal of Chengde Medical University, 2019, 36(1): 11-15.
[11]	. [J]. Journal of Chengde Medical University, 2018, 35(6): 475-477.
[12]	ZHANG Yun-peng, CHEN Xiao, LI Jing, et al. EFFECTS OF TYPE H HYPERTENSION ON PROGNOSIS OF INTRAVENOUS THROMBOLYSIS IN PATIENTS WITH ACUTE CEREBRAL INFARCTION [J]. Journal of Chengde Medical University, 2018, 35(4): 285-288.
[13]	LIU Si-yang, WU Jian-long, QIAO Jian-yong, et al. CHANGES AND SIGNIFICANCE OF SERUM TNF-Α, VEGF AND ET-1 LEVEL IN PATIENTS WITH HYPERTENSIVE CEREBRAL HEMORRHAGE [J]. Journal of Chengde Medical University, 2018, 35(4): 296-298.
[14]	. [J]. Journal of Chengde Medical University, 2018, 35(3): 253-255.
[15]	. [J]. Journal of Chengde Medical University, 2018, 35(2): 114-116.